These results lend greater credence to the hypothesis that AD patients are much more vulnerable to cutaneal infections due to aberrant TLR2 expression, a loss of downstream signaling cascade in epidermal DC, and elevations in levels of DC markers such as CD83 and other T cell markers [99,124]. Here, CD83 is linked to Alzheimer disease.